Dear colleagues,

It is a great pleasure to welcome you to the 3rd International Electronic Conference on Biomedicines (ECB 2025), which will be held from 12 to 15 May 2025. This electronic conference will be held online at https://sciforum.net/event/ECB2025.

The goal of this conference is to enable scientists to present their latest research in the field of biomedicines and engage in discussions with the scientific community worldwide. Recent advances in biomedical research have provided an advanced insight into the biological background of human disease, setting the groundwork for the development of new therapeutic strategies. This conference aims to connect scientists working on this field of research from across the globe, allowing them to exchange ideas on the discovery and characterization of new therapeutic targets in the era of precise medicine.

The agenda of the conference includes, but is not limited to, the following topics:

S1. Insulin Resistance or Hyperinsulinemia
S2. Immunotherapy and Adverse Effects
S3. Tumor Microenvironment
S4. Immune System, Tumor Immunology and Autoimmune Disease
S5. Biomedicine in Cardiovascular Diseases
S6. Diabetes, Obesity and Metabolic Diseases
S7. Gene Therapy and Gene Editing
S8. Rare Diseases
S9. Molecular Mechanisms of Neurodegeneration

The ECB 2025 will be an online-only event, enabling scientists from all over the world to participate, with a small registration fee, but with no requirement for travel or related expenses. The electronic form of the conference provides a platform for rapid and direct exchanges regarding the latest research findings and novel ideas.

All participants are encouraged to submit an extended full manuscript for potential publication in the Biomedicines journal (ISSN: 2227-9059), with a 20% discount on the publication fee. All submitted papers will undergo MDPI’s standard peer-review procedure.

We look forward to receiving your contributions to this scientific event, and we would like to thank you in advance for your support.

Conference chairs
Prof. Dr. Felipe Fregni
Prof. Dr. Allan Stensballe
Prof. Dr. Georgia Levidou
Prof. Dr. Serafino Fazio

Follow the conference organizer on Social Media

Sessions

The 3rd International Electronic Conference on Biomedicines will accept abstracts only. The accepted abstracts will be available online on Sciforum.net during and after the conference.

1. Deadline for abstract submission: 19 January 2025 .
2. Abstract Acceptance Notification: 19 February 2025. You will be notified of the acceptance of an oral/poster presentation in a separate email.

Abstract submissions should be completed online by registering with www.sciforum.net and using the "New Submission" function once logged into the system. No physical template is necessary.

1. The structure abstract should include the introduction, methods, results, and conclusions sections of about 250–300 words in length.
2. All accepted abstracts will be published in the conference report of The 3rd International Electronic Conference on Biomedicines in Medical Sciences Forum Journal (ISSN 2673-9992); if you wish to publish an extended proceeding paper (5-9 pages), please submit it to the same journal after the conference.
3. All abstracts should be submitted and presented in clear, publication-ready English with accurate grammar and spelling.
4. You may submit multiple abstracts. However, only one abstract will be selected for oral presentation.
5. All abstracts accepted for presentation will be collected in a book of abstracts, which will be published on the website after the conference.

Detailed Requirements:
1. The submitting author must ensure that all co-authors are aware of the contents of the abstract.
2. Please select only one presenter for each submission. If you would like to change the presenter after submission, please email us accordingly.

Note: We only accept live presentations.

The slot for the oral presentation is 15 mins. We advise that your presentation lasts for a maximum of 12 mins, leaving at least 3 mins for the Q&A session. Authors are encouraged to prepare a presentation in PowerPoint or similar software.

a. Your submission should include the title, authors, contact details, and main research findings, as well as tables, figures, and graphs where necessary.
b. File format: PDF (.pdf).
c. Size in cm: 60 width x 80 height–portrait orientation.
d. Font size: ≥20.
e. Maximum size: 250 M

You can use our free template to create your poster. The poster template can be downloaded here.

The Poster Sessions will take place in Zoom break-out rooms. The rooms will be called after your surname. You will automatically be assigned to your break-out room, however, you will be responsible for your own room, i.e. sharing your screen by yourself, handling the comments in the chat if there are any, etc. People will then be able to visit your room and discuss your poster with you. Please make sure you have the Zoom Desktop client or mobile app, version 5.3.0 or higher.
We will reach out to you closer to the dates of the conference with more information.

It is the authors' responsibility to identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of clinical research. If there is no conflict, please state "The authors declare no conflicts of interest." This should be conveyed in a separate "Conflict of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. Any financial support for the study must be fully disclosed in the "Acknowledgments" section.

MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe authors should retain the copyright to their scholarly works. Hence, by submitting an abstract to this conference, you retain the copyright to the work, but you grant MDPI the non-exclusive right to publish this abstract online on the Sciforum.net platform. This means you can easily submit your full paper (with the abstract) to any scientific journal at a later stage and transfer the copyright to its publisher if required.